Denise M Boudreau

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi request reprint Collaborative care model to improve outcomes in major depression
    Denise M Boudreau
    Department of Pharmacy, University of Washington, Seattle, WA 98195 7630, USA
    Ann Pharmacother 36:585-91. 2002
  2. pmc Measurement of opioid problems among chronic pain patients in a general medical population
    Caleb J Banta-Green
    Alcohol and Drug Abuse Institute, University of Washington, Seattle, WA 98105, USA
    Drug Alcohol Depend 104:43-9. 2009
  3. pmc Cardiovascular medication use and risk for colorectal cancer
    Denise M Boudreau
    Group Health Center for Health Studies, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 17:3076-80. 2008
  4. pmc Cost of breast-related care in the year following false positive screening mammograms
    Jessica Chubak
    Group Health Research Institute, Seattle, WA 98101 1448, USA
    Med Care 48:815-20. 2010
  5. pmc Colorectal cancer risk in relation to antidepressant medication use
    Jessica Chubak
    Group Health Research Institute, Group Health, Seattle, WA 98101 1448, USA
    Int J Cancer 128:227-32. 2011
  6. ncbi request reprint Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care
    Kam L Capoccia
    Departments of Pharmacy and Family Medicine, University of Washington, Seattle, USA
    Am J Health Syst Pharm 61:364-72. 2004
  7. pmc Frequent antibiotic use and second breast cancer events
    Heidi S Wirtz
    Departments of Pharmacy, Biostatistics, Epidemiology, and Health Services, University of Washington, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 22:1588-99. 2013
  8. pmc Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer
    Erin J Aiello Bowles
    Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    J Oncol Pract 8:e149-57. 2012
  9. ncbi request reprint The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study
    Denise M Boudreau
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA
    Cancer 100:2308-16. 2004
  10. pmc Statin use and cancer risk: a comprehensive review
    Denise M Boudreau
    Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Expert Opin Drug Saf 9:603-21. 2010

Detail Information

Publications33

  1. ncbi request reprint Collaborative care model to improve outcomes in major depression
    Denise M Boudreau
    Department of Pharmacy, University of Washington, Seattle, WA 98195 7630, USA
    Ann Pharmacother 36:585-91. 2002
    ..To develop a pharmacist intervention to improve depression care and outcomes within a primary care setting...
  2. pmc Measurement of opioid problems among chronic pain patients in a general medical population
    Caleb J Banta-Green
    Alcohol and Drug Abuse Institute, University of Washington, Seattle, WA 98105, USA
    Drug Alcohol Depend 104:43-9. 2009
    ..The utility of the PDUQ and its relationship with the DSM-IV approach needs to be established for patients being treated in general medical settings...
  3. pmc Cardiovascular medication use and risk for colorectal cancer
    Denise M Boudreau
    Group Health Center for Health Studies, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 17:3076-80. 2008
    ..We hypothesized a reduction in colorectal cancer risk with 3-hydroxy-3-methylglutaryl coA reductase inhibitors (statins) and angiotensin-converting enzyme inhibitors...
  4. pmc Cost of breast-related care in the year following false positive screening mammograms
    Jessica Chubak
    Group Health Research Institute, Seattle, WA 98101 1448, USA
    Med Care 48:815-20. 2010
    ..We sought to estimate the direct cost, from the perspective of the health insurer or purchaser, of breast-care services in the year following a false positive screening mammogram compared with a true negative examination...
  5. pmc Colorectal cancer risk in relation to antidepressant medication use
    Jessica Chubak
    Group Health Research Institute, Group Health, Seattle, WA 98101 1448, USA
    Int J Cancer 128:227-32. 2011
    ..Future studies with larger sample sizes should further examine individual drugs as well as dose, duration and recency of use...
  6. ncbi request reprint Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care
    Kam L Capoccia
    Departments of Pharmacy and Family Medicine, University of Washington, Seattle, USA
    Am J Health Syst Pharm 61:364-72. 2004
    ..The impact of pharmacist interventions on the care and outcomes of patients with depression in a primary care setting was evaluated...
  7. pmc Frequent antibiotic use and second breast cancer events
    Heidi S Wirtz
    Departments of Pharmacy, Biostatistics, Epidemiology, and Health Services, University of Washington, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 22:1588-99. 2013
    ..Antibiotic use may be associated with higher breast cancer risk and breast cancer mortality, but no study has evaluated the relation between antibiotic use and second breast cancer events (SBCE)...
  8. pmc Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer
    Erin J Aiello Bowles
    Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    J Oncol Pract 8:e149-57. 2012
    ..We conducted a larger self-report evaluation of endocrine therapy discontinuation associated with patient characteristics and therapy-related adverse effects...
  9. ncbi request reprint The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study
    Denise M Boudreau
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA
    Cancer 100:2308-16. 2004
    ..However, statins have been found to be carcinogenic in rodents and one clinical trial found an excess of breast carcinoma cases in the treatment group...
  10. pmc Statin use and cancer risk: a comprehensive review
    Denise M Boudreau
    Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Expert Opin Drug Saf 9:603-21. 2010
    ..They are among the most commonly prescribed drugs worldwide. Contrary to early concerns over the carcinogenicity of statins, a growing body of evidence suggests statins may in fact have a chemopreventive potential against cancer...
  11. pmc Statin use and breast cancer risk in a large population-based setting
    Denise M Boudreau
    Group Health, Center for Health Studies, Suite 1600, 1730 Minor Avenue, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 16:416-21. 2007
    ..Mechanistic studies suggest that 3-hydroxy-3-methylglutaryl CoA inhibitors (statins) reduce the risk of breast cancer. Observational studies offer mixed results...
  12. pmc Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors
    Heidi S Wirtz
    Department of Pharmacy, University of Washington, 1959 NE Pacific St, Box 357630, Seattle, WA, 98195, USA
    Breast Cancer Res Treat 143:541-50. 2014
    ..Efforts should be undertaken to actively engage breast cancer survivors in managing long-term surveillance care...
  13. pmc Bone mineral density screening among women with a history of breast cancer treated with aromatase inhibitors
    Leslie Spangler
    Group Health Research Institute, Seattle, WA 98101, USA
    J Womens Health (Larchmt) 22:132-40. 2013
    ..Understanding adherence to bone mineral density (BMD) screening after breast cancer (BC) treatment with aromatase inhibitors (AI) is an important first step in preventing or treating BC-related osteoporosis...
  14. doi request reprint Concomitant use of cholinesterase inhibitors and anticholinergics: prevalence and outcomes
    Denise M Boudreau
    Department of Pharmacy, University of Washington, Seattle, WA, USA
    J Am Geriatr Soc 59:2069-76. 2011
    ..To determine the extent of concomitant use of cholinesterase inhibitor (ChI) and anticholinergic (ACh) medications and the clinical consequences of dual use in a population-based setting...
  15. ncbi request reprint Antidepressant use and breast cancer risk
    Chloe Chien
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Breast Cancer Res Treat 95:131-40. 2006
    ..However, human studies evaluating use of antidepressants in relation to breast cancer risk have yielded inconsistent results...
  16. pmc Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer
    Denise M Boudreau
    Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA, 98101, USA
    Breast Cancer Res Treat 144:405-16. 2014
    ..A majority of CVD medications evaluated in this study appear safe with respect to SBCE, but ACEI and BB use warrant further evaluation. The study presented is one example of the questions that can be addressed using the COMBO cohort...
  17. pmc Influence of body mass index on the choice of therapy for depression and follow-up care
    Denise M Boudreau
    Group Health Research Institute, Group Health Cooperative, Seattle, WA, USA
    Obesity (Silver Spring) 21:E303-13. 2013
    ..We conducted a cohort study to investigate whether obesity is associated with treatment choices for depression; and whether obesity is associated with appropriate duration of depression treatment and receipt of follow-up visits...
  18. pmc Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival
    Jessica Chubak
    Affiliations of authors Group Health Research Institute, Seattle, WA JC, DMB, HSW Department of Epidemiology JC, NSW, Department of Pharmacy DMB, HSW, and Department of Biostatistics BM, University of Washington, Seattle, WA Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, WA NSW
    J Natl Cancer Inst 105:1456-62. 2013
    ..Attention to known challenges in epidemiologic research is critical for the validity of studies of postdiagnosis exposures and cancer outcomes. ..
  19. pmc Statin use and prostate cancer risk in a large population-based setting
    Denise M Boudreau
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Cancer Causes Control 19:767-74. 2008
    ..Statins are a commonly used cholesterol-lowering drug, which also have the potential to affect cancer risk and progression. Results from previous studies offer mixed conclusions...
  20. pmc The influence of statin use on breast density
    Denise M Boudreau
    Group Health Cooperative, Center for Health Studies, Suite 1600, 1730 Minor Avenue, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 15:1026-9. 2006
    ..To evaluate if 3-hydroxy-3-methylglutaryl CoA reductase reductase inhibitor use (statins) alters mammography measured breast density...
  21. pmc Concordance of population-based estimates of mammography screening
    Denise M Boudreau
    Group Health Center for Health Studies, Seattle, WA 98101, USA
    Prev Med 45:262-6. 2007
    ..This study estimated adherence to repeat (two successive on-time screenings) and regular screening (three or more successive screenings) and evaluated the impact of varying operational definitions and evaluation periods...
  22. pmc Breast cancer recurrence risk in relation to antidepressant use after diagnosis
    Jessica Chubak
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101 1448, USA
    Breast Cancer Res Treat 112:123-32. 2008
    ....
  23. pmc Statin use and female reproductive organ cancer risk in a large population-based setting
    Onchee Yu
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Cancer Causes Control 20:609-16. 2009
    ..We evaluated the association between statin use and endometrial as well as ovarian cancer risks...
  24. pmc A model of cost-effectiveness of tissue plasminogen activator in patient subgroups 3 to 4.5 hours after onset of acute ischemic stroke
    Denise M Boudreau
    University of Washington, Seattle, WA, USA
    Ann Emerg Med 61:46-55. 2013
    ..We evaluate the long-term incremental cost-effectiveness of rtPA administered 3 to 4.5 hours after acute ischemic stroke onset versus no treatment according to patient clinical and demographic factors...
  25. doi request reprint A survey of adult awareness and use of medicine containing acetaminophen
    Denise M Boudreau
    Group Health Research Institute, Seattle, WA 98101, USA
    Pharmacoepidemiol Drug Saf 22:229-40. 2013
    ..To compare awareness, use of acetaminophen, and preferences for receiving information aimed at reducing acetaminophen overdose...
  26. doi request reprint Cardiovascular events associated with ipratropium bromide in COPD
    Sarika S Ogale
    Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Seattle, WA, USA
    Chest 137:13-9. 2010
    ..We sought to examine the association between ipratropium bromide use and the risk of cardiovascular events (CVEs)...
  27. ncbi request reprint Impact of hormone therapy on false-positive recall and costs among women undergoing screening mammography
    Denise M Boudreau
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101 1448, USA
    Med Care 44:62-9. 2006
    ..We sought to evaluate the effects of hormone therapy (HT) on false-positive (FP) recall for additional breast evaluation and costs...
  28. pmc Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment
    Gregory S Calip
    Department of Epidemiology, University of Washington, Seattle, WA, USA
    Breast Cancer Res Treat 138:225-33. 2013
    ..Understanding the influence of life events such as cancer diagnosis and treatment on management of comorbidities and adherence to preventive therapies are important to the growing population of breast cancer survivors...
  29. pmc Opioid use behaviors, mental health and pain--development of a typology of chronic pain patients
    Caleb J Banta-Green
    Alcohol and Drug Abuse Institute, University of Washington, Seattle, WA 98105, USA
    Drug Alcohol Depend 104:34-42. 2009
    ..Aims were to improve our understanding of this population as well as to explore ways of identifying different types of patients...
  30. doi request reprint Accuracy of ICD-9 codes to identify nonunion and malunion and developing algorithms to improve case-finding of nonunion and malunion
    Denise M Boudreau
    Group Health Research Institute, Seattle, WA 98101, USA
    Bone 52:596-601. 2013
    ..To evaluate the accuracy of using ICD-9 codes to identify nonunions (NU) and malunions (MU) among adults with a prior fracture code and to explore case-finding algorithms...
  31. doi request reprint The cost-effectiveness of primary stroke centers for acute stroke care
    Gregory F Guzauskas
    University of Washington, Seattle, WA 98195, USA
    Stroke 43:1617-23. 2012
    ..The objective of this study was to evaluate the cost-effectiveness of treating AIS patients in a PSC compared with a nonPSC hospital setting...
  32. pmc Colorectal cancer risk in relation to use of acid suppressive medications
    Jessica Chubak
    Group Health Center for Health Studies, Seattle, WA 98101 1448, USA
    Pharmacoepidemiol Drug Saf 18:540-4. 2009
    ..A few epidemiologic studies have investigated acid suppressant use and CRC risk; none has documented an overall association. We sought to investigate whether acid suppressants are associated with CRC risk...
  33. ncbi request reprint A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women
    Denise M Boudreau
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Am J Epidemiol 159:308-17. 2004
    ..Trivial changes in estimates were observed when health maintenance organization records alone were used as the gold standard. Self-reported use of antihypertensives and statins appears to be relatively accurate among older women...